An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
Clinical trial NCT00207155 · COMPLETED
Trial details
- NCT number
- NCT00207155
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2006-02-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.